Evidence map›Paper›PMID 35055967›Full record

ArticlePathogens (Basel, Switzerland)2021

Distinct

Kathrin Arndts, Tayseer E M Elfaki, Michael J Doenhoff, Gnatoulma Katawa, Ibtisam A Goreish, Misk El Yemen A Atti El Mekki, Achim Hoerauf, Manuel Ritter, Laura E Layland

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Kathrin ArndtsInstitute of Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital Bonn (UKB), 53127 Bonn, Germany.ORCID 0000-0003-1091-4861
Tayseer E M ElfakiDepartment of Parasitology and Medical Entomology, College of Medical Laboratory Science, Sudan University of Science and Technology, Khartoum 13311, Sudan.
Michael J DoenhoffSchool of Life Sciences, University of Nottingham, University Park, Nottingham NG7 2RD, UK.
Gnatoulma KatawaUnité de Recherche en Immunologie et Immunomodulation (UR2IM), Ecole Supérieure des Techniques Biologiques et Alimentaires (ESTBA), University of Lome, Lomé BP 1515, Togo.ORCID 0000-0002-4591-5672
Ibtisam A GoreishAnimal Resources Research Corporation, Ministry of Livestock, Fisheries and Rangelands, Khartoum 13311, Sudan.
Misk El Yemen A Atti El MekkiDepartment of Parasitology and Medical Entomology, College of Medical Laboratory Science, Sudan University of Science and Technology, Khartoum 13311, Sudan.
Achim HoeraufInstitute of Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital Bonn (UKB), 53127 Bonn, Germany.
Manuel RitterInstitute of Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital Bonn (UKB), 53127 Bonn, Germany.ORCID 0000-0001-8667-2067
Laura E LaylandInstitute of Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital Bonn (UKB), 53127 Bonn, Germany.
University Hospital Bonn · DESudan University of Science and Technology · SDUniversity of Lomé · TGUniversity of Nottingham · GB

Funding

Deutsche Forschungsgemeinschaft LA 2746/2-1
6 · The paper itself

Abstract

Despite the existence of an effective medication against schistosomiasis, the disease remains a major health problem in affected areas, especially for those lacking appropriate sanitary facilities. Moreover, treatment cannot prevent re-infection since it is only effective on adult schistosome worms. Previous retrospective studies in the Sudan have discovered unique immuno-epidemiological profiles in uninfected individuals and those positive for

Indexed as

cercarial transformation fluid (SmCTF)immunoglobulinsmultivariable regression analysisSchistosoma mansoniSudan

Identifiers

PMID35055967
PMCPMC8778779
OpenAlexW4200061967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.